D1-5-(2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl thiazolidine-2,4-dione as an anti-atherosclerosis agent
CA 1313139 C · Owner: Swindell, Archie Calhound · Inventors: Krupp, Michael Norman; Swindell, Archie Calhound
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
PATENT, PC 7301, dl-5-(2-BENZYL-3,4-DIHYDRO-2H-BENZOPYRAN- 6-YL)METHYLTHIAZOLIDINE-2,4-DIONE AS AN ANTI-ATHEROSCLEROSIS AGENT. Abstract, This invention relates of the use of a certain thiazolidine-2,4-dione, namely, dl-5-(2-benzyl-3,4dihydro-2H-benzopyran-6-yl)methylthiazolidine-2,4dione, or a pharmaceutically acceptable cationic salt thereof, for retarding the development of arterial disease in mammals. More specifically, it relates to a method for reducing the serum cholesterol levels in mammals by administering to said mammals dl-5-(2benzyl-3,4-dihydro-2H-benzopyran-6-yl)methylthiazolidine-2,4-dione or a pharmaceutically acceptable cationic salt thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted January 26, 1993. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended January 26, 2010.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.